HONOLULU (KHON) — What does a healthy liver look like? The University of Hawaii John A. Burns School of Medicine is offering free liver testing for the public to join their liver health study. “This ...

A new scoring system using common clinical parameters accurately identifies chronic liver disease patients with a significantly increased risk of developing liver cancer. This tool acts as a universal ...

Yes, your liver helps your body process that glass of wine you had with dinner last night, but it also does so much more. “The liver works hard daily to metabolize nutrients, filter out toxins, and ...

(RTTNews) - Exact Sciences Corp. (EXAS), Friday announced the landmark clinical results from its ALTUS study, showing that the Oncoguard Liver blood test significantly outperforms ultrasound in ...

ALTUS study is the largest prospective trial of a blood test for liver cancer surveillance in the United States, reflecting the racial and ethnic diversity of high-risk groups Exact Sciences Corp.

The FDA has halted clinical testing of an Intellia Therapeutics gene-editing therapy following a report that a patient in a Phase 3 study was hospitalized with liver complications. Intellia said the ...

Dear Dr. Roach: I'm a generally healthy 73-year-old man. I recently had blood work done and was incidentally noted to have high liver tests (ALT and AST). My doctor ordered a sonogram, which said that ...

Researchers in Sweden and Finland have created the CORE model, a simple blood test that predicts liver disease risk with striking accuracy. Unlike current methods, it works for the general population ...

University of Victoria provides funding as a member of The Conversation CA-FR. University of Victoria provides funding as a member of The Conversation CA. Research has revealed a steep increase in ...

Notre Dame didn't answer all the questions in Saturday's win over Purdue but it was certainly a step in the right direction despite some first half struggles. The 1-2 Fighting Irish now hit the road ...

Following a single subcutaneous 240 mg dose, WVE-007 (INHBE GalNAc-siRNA) improved body composition at three months compared to baseline, with a 9.4% reduction in visceral fat (p=0.02), a 4.5% ...